Skip to main content
SpringerLink
Log in
Book cover

Single Agents in Cancer Chemotherapy pp 173–194Cite as

6-Mercaptopurine

  • Chapter

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   39.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Burchenal, J., and Ellison, R. The pyrimidine and purine antagonists. Clin Pharmacol Ther 2: 523, 1961.

    PubMed  CAS  Google Scholar 

  2. Calabresi, P., and Welch, A. Chemotherapy of neoplastic diseases. Ann Rev Med 13: 147, 1962.

    Article  PubMed  CAS  Google Scholar 

  3. Elion, G., Callahan, S., Rundles, R., et al. Relationship between metabolic fates and antitumor activities of thiopurines. Cancer Res 23: 1207, 1963.

    PubMed  CAS  Google Scholar 

  4. Brockman, R. Biochemical aspects of mercaptopurine inhibition and resistance. Cancer Res 23: 1191, 1963.

    PubMed  CAS  Google Scholar 

  5. Burchenal, J., Ellison, R., Murphy, M., et al. Clinical studies on 6-mercaptopurine. Ann N Y Acad Sci 60: 359, 1954.

    Article  PubMed  CAS  Google Scholar 

  6. Hall, B., Richards, M., Willett, F., et al. Clinical experience with 6-mercaptopurine in human neoplasia. Ann N Y Acad Sci 60: 374, 1954.

    Article  PubMed  CAS  Google Scholar 

  7. Bernard, J., and Seligmann, M. A study of 61 leukemias treated with 6-mercaptopurine. Ann N Y Acad Sci 60: 385, 1954.

    Article  PubMed  CAS  Google Scholar 

  8. Farber, S. Summary of experience with 6-mercaptopurine. Ann N Y Acad Sci 60: 412, 1954.

    Article  PubMed  CAS  Google Scholar 

  9. Pierce, M. Leukemia in children: treatment of 22 cases with 6-mercaptopurine. Ann N Y Acad Sci 60: 415, 1954.

    Article  PubMed  CAS  Google Scholar 

  10. Rundles, R., and Crago, J. 6-mercaptopurine therapy in neoplastic disease. Ann N Y Acad Sci 60: 425, 1954.

    Article  PubMed  CAS  Google Scholar 

  11. Hyman, G., Gellhorn, A., and Wolff, J. The therapeutic effect of mercaptopurine in a variety of human neoplastic diseases. Ann N Y Acad Sci 60: 430, 1954.

    Article  PubMed  CAS  Google Scholar 

  12. Bethell, F., and Thompson, D. Treatment of leukemia and related disorders with 6-mercaptopurine. Ann N Y Acad Sci 60: 436, 1954.

    Article  PubMed  CAS  Google Scholar 

  13. Fountain, J. Clinical observations of the treatment of leukemia and allied disorders with 6-mercaptopurine. Ann N Y Acad Sci 60: 439, 1954.

    Article  PubMed  CAS  Google Scholar 

  14. Rosenthal, N., Rosenthal, R., and Lee, S. Role of mercaptopurine in the treatment of leukemia and related diseases. Ann N Y Acad Sci 60: 448, 1954.

    Article  PubMed  CAS  Google Scholar 

  15. Gaffney, P., and Cooper, W. A clinical study of 6mercaptopurine. Ann N Y Acad Sci 60: 478, 1954.

    Article  PubMed  CAS  Google Scholar 

  16. Wilson, S. The clinical and hematologic response of previously treated leukemic subjects to the antimetabolite 6-mercaptopurine. Ann N Y Acad Sci 60: 499, 1954.

    Article  PubMed  CAS  Google Scholar 

  17. Hayhoe, F. 6-mercaptopurine in acute leukemia. Lancet 3: 903, 1955.

    Article  Google Scholar 

  18. Fountain, J. Treatment of chronic myeloid leukemia with mercaptopurine. Brit Med J 2: 1345, 1956.

    Article  PubMed  CAS  Google Scholar 

  19. Whitelaw, D., Moffat, R., Perry, W., et al. Acute leukemia in adults treated with 6-mercaptopurine. Canad Med Assoc 74: 423, 1956.

    CAS  Google Scholar 

  20. Greig, H., Metz, J., Laird, M., et al. Chemotherapy of leukemia. II. 6-mercaptopurine (“Purinethol”) in the treatment of acute leukemia and some other neoplastic diseases of the reticuloendothelial system. South African Med J 30: 360, 1956.

    CAS  Google Scholar 

  21. Hyman, C., Brubaker, C., and Sturgeon, P. 6-mercaptopurine in childhood leukemia: comparison of large dose interrupted with small dose continuous therapy. Cancer Res 17: 851, 1957.

    PubMed  CAS  Google Scholar 

  22. Ellison, R., Silver, R., and Engle, R. Comparative study of 6-chloropurine and 6-mercaptopurine in acute leukemia in adults. Ann Intern Med 51: 322, 1959.

    PubMed  CAS  Google Scholar 

  23. Heyn, R., Brubaker, C., Burchenal, J., et al. The comparison of 6-mercaptopurine with the combination of 6-mercaptopurine and azaserine in the treatment of acute leukemia in children: Results of a cooperative study. Blood 15: 350, 1960.

    PubMed  CAS  Google Scholar 

  24. Ellison, R., and Burchenal, J. Treatment of chronic granulocytic leukemia with the 6-substituted purines 6mercaptopurine, thioguanine, and 6-chloropurine. Clin Pharm Ther 1: 631, 1960.

    CAS  Google Scholar 

  25. Fountain, J. Treatment of chronic myeloid leukemia with mercaptopurine. Acta Unio Int Cancer 16: 846, 1960.

    CAS  Google Scholar 

  26. Frei, E., Freireich, E., Gehan, E., et al. Studies of sequential and combination antimetabolite therapy in acute leukemia: 6-mercaptopurine and methotrexate. Blood 18: 431, 1961.

    Google Scholar 

  27. Sullivan, M., Beatty, E., Hyman, C., et al. A comparison of the effectiveness of standard dose 6-mercaptopurine, combination 6-mercaptopurine and DON, and high-loading 6-mercaptopurine therapies in the treatment of acute leukemia in children: results of a cooperative study. Cancer Chemother Rep 16: 161, 1962, and Cancer Chemother Rep 18: 83, 1962.

    CAS  Google Scholar 

  28. Shullenberger, C. Evaluation of the comparative effectiveness of Myleran and 6 MP in the management of patients with chronic myelocytic leukemia. Cancer Chemother Rep 16: 203, 1962.

    PubMed  CAS  Google Scholar 

  29. Shullenberger, C. Long-range treatment of polycythemia vera with 6-mercaptopurine. Cancer Chemother Rep 16: 251, 1962.

    PubMed  CAS  Google Scholar 

  30. Whittington, R., Rivers, S., Doyle, R., et al. Acute leukemia in the adult male. I. Comparative effect of 6mercaptopurine and 6-chloropurine. Cancer Chemother Rep 18: 73, 1962.

    PubMed  CAS  Google Scholar 

  31. Bridges, J., Hayes, D., and Nelson, M. Therapy of acute leukemia: comparison of initial treatment with 6-mercaptopurine alone and of combination with steroids. Brit J Cancer 16: 46, 1962.

    Article  PubMed  CAS  Google Scholar 

  32. Sutow, W., Haggard, M., Blattner, R., et al. Studies of ACTH, hydrocortisone, and 6-mercaptopurine in the treatment of children with acute leukemia. J Pediat 61: 693, 1962.

    Article  PubMed  CAS  Google Scholar 

  33. Huguley, C., Grizzle, J., Rundles, R., et al. Comparison of 6-mercaptopurine and busulfan in chronic granulocytic leukemia. Blood 21: 89, 1963.

    Google Scholar 

  34. Working party on the evaluation of different methods of therapy in leukemia. Brit Med J 1: 7, 1963.

    Article  Google Scholar 

  35. Regelson, W., Holland, J., Frei, E., et al. Comparative clinical toxicity of 6-mercaptopurine and 6-mercaptopurine ribonucleoside administered intravenously to patients with advanced cancer. Cancer Chemother Rep 36: 41, 1964.

    PubMed  CAS  Google Scholar 

  36. Lemon, H., Miller, D., Smith, J., et al. Remission of metastases of erythropoietin - secreting renal cell adenocarcinoma after 6-mercaptopurine therapy. Cancer Chemother Rep 36: 49, 1964.

    PubMed  CAS  Google Scholar 

  37. Ellison, R., and Hoogstraten, B. Intravenous 6-mercaptopurine and methotrexate in adults with acute leukemia. Proc Amer Assoc Cancer Res 6: 17, 1965.

    Google Scholar 

  38. Working party on the evaluation of different methods of therapy in leukemia. Brit Med J 1: 1383, 1966.

    Article  Google Scholar 

  39. Moore, G., Bross, I., Ausman, R. Effects of 6-mercaptopurine in 290 patients with advanced cancer. Cancer Chemother Rep 52: 655, 1968.

    PubMed  CAS  Google Scholar 

  40. Boggs, D., Wintrobe, M., and Cartwright, G. To treat or not to treat acute granulocytic leukemia. II. Arch Intern Med 123: 568, 1969.

    Article  CAS  Google Scholar 

  41. Fink, D., and Foye, L., Jr. 6-mercaptopurine (NSC 755) given intermittently in high doses: Phase II study. Cancer Chemother Rep 54: 31, 1970.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. National Cancer Institute, Bethesda, Maryland, USA

    Robert B. Livingston & Stephen K. Carter

Authors
  1. Robert B. Livingston
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Stephen K. Carter
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 1970 IFI/Plenum · New York-Washington-London

About this chapter

Cite this chapter

Livingston, R.B., Carter, S.K. (1970). 6-Mercaptopurine. In: Single Agents in Cancer Chemotherapy. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-1378-6_8

Download citation

  • DOI: https://doi.org/10.1007/978-1-4684-1378-6_8

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4684-1380-9

  • Online ISBN: 978-1-4684-1378-6

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation